Skip to main content

and
  1. Article

    Open Access

    NTRK-rearranged spindle cell sarcoma of the uterine cervix with a novel NUMA1::NTRK1 fusion

    NTRK-rearranged uterine sarcoma is a recently described entity that represents a subset of uterine sarcomas with distinct clinicopathological features. From a molecular point of view, this tumour is defined by NT...

    Luca Szalai, Ildikó Vereczkey, Marianna Szemes, András Rókusz in Virchows Archiv (2024)

  2. Article

    Open Access

    Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting

    Tumor heterogeneity is a consequence of clonal evolution, resulting in a fractal-like architecture with spatially separated main clones, sub-clones and single-cells. As sequencing an entire tumor is not feasib...

    Lőrinc S. Pongor, Gyöngyi Munkácsy, Ildikó Vereczkey, Imre Pete in Scientific Reports (2020)

  3. No Access

    Article

    Pathologic Complete Remission after Preoperative High-Dose-Rate Brachytherapy in Patients with Operable Cervical Cancer: Preliminary Results of a Prospective Randomized Multicenter Study

    The role of preoperative intrauterine brachytherapy (BT) in the multidisciplinary treatment of early stage cervical carcinoma (ESCC) is controversial. In 2005, a prospective randomized multicenter study was in...

    Julia Vízkeleti, Ildikó Vereczkey, Georgina Fröhlich in Pathology & Oncology Research (2015)

  4. No Access

    Article

    Evaluation of the Accuracy of Preoperative MRI in Measuring Myometrial Infiltration in Endometrial Carcinoma

    The aim of our study was to evaluate the diagnostic performance of magnetic resonance imaging (MRI) in the pretreatment evaluation of myometrium invasion in endometrial cancer. Our retrospective study concerns...

    Katalin Horváth, Imre Pete, Ildikó Vereczkey in Pathology & Oncology Research (2014)

  5. No Access

    Article

    Molecular Characterization of 103 Ovarian Serous and Mucinous Tumors

    The pathogenesis of ovarian carcinomas is heterogeneous, with even the same entities showing great variance. In our study we investigated the mutations of the BRAF, KRAS, and p53 genes in serous and mucinous b...

    Ildikó Vereczkey, Orsolya Serester, Judit Dobos in Pathology & Oncology Research (2011)